Back
NV5 Global Vs. Mirum Pharmaceuticals Industry Stock Comparison
Sell
26
NVEE
NV5 Global
Last Price:
92.86
Seasonality Move:
9.24%
Sell
44
MIRM
Mirum Pharmaceuticals
Last Price:
39.35
Seasonality Move:
5.99%
Sell
26
NV5 Global (NVEE)
is a Sell
Is NV5 Global a Buy, Sell or Hold?
- The current NV5 Global [NVEE] share price is $92.91. The Score for NVEE is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- NVEE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Mirum Pharmaceuticals (MIRM)
is a Sell
Is Mirum Pharmaceuticals a Buy, Sell or Hold?
- The current Mirum Pharmaceuticals [MIRM] share price is $39.34. The Score for MIRM is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- MIRM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVEE Stock Price Chart
What is NV5 Global's stock price today?
-
The NV5 Global share price today is $92.91
The current trend is relatively stagnant and NVEE is experiencing slight selling pressure.
MIRM Stock Price Chart
What is Mirum Pharmaceuticals's stock price today?
-
The Mirum Pharmaceuticals share price today is $39.34
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MIRM is experiencing slight buying pressure.
NVEE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.28 | Sell |
Relative Strength Index (14 RSI): | 49.95 | Sell |
Chaikin Money Flow: | -14864 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (90.56 - 95.76) | Sell |
Bollinger Bands (100): | (91.04 - 97.9) | Sell |
MIRM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.23 | Sell |
Relative Strength Index (14 RSI): | 44.04 | Sell |
Chaikin Money Flow: | 27576 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.13 - 42.69) | Sell |
Bollinger Bands (100): | (27.3 - 41.42) | Buy |
NVEE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 90.78 | Buy |
20-day SMA: | 92.57 | Buy |
50-day SMA: | 95.99 | Sell |
200-day SMA: | 98.52 | Sell |
8-day EMA: | 91.36 | Buy |
20-day EMA: | 92.34 | Buy |
50-day EMA: | 93.98 | Sell |
200-day EMA: | 97.37 | Sell |
MIRM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.48 | Sell |
20-day SMA: | 41.45 | Sell |
50-day SMA: | 40.72 | Sell |
200-day SMA: | 31.06 | Buy |
8-day EMA: | 40.12 | Sell |
20-day EMA: | 40.8 | Sell |
50-day EMA: | 39.41 | Sell |
200-day EMA: | 32.87 | Buy |
NV5 Global Earnings Growth & NVEE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.18 per share, an increase this year of $0.31 per share, and an increase next year of $0.45 per share.
Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.30 per share, an increase this year of $1.79 per share, and an increase next year of $0.88 per share.
NV5 Global Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Mirum Pharmaceuticals Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |